The anti-seizure drugs vinpocetine and carbamazepine, but not valproic acid, reduce inflammatory IL-1β and TNF-α expression in rat hippocampus

J Neurochem. 2014 Sep;130(6):770-9. doi: 10.1111/jnc.12784. Epub 2014 Jun 27.

Abstract

In the present study, the effects of the two classical anti-epileptic drugs, carbamazepine and valproic acid, and the non-classical anti-seizure drug vinpocetine were investigated on the expression of the pro-inflammatory cytokines IL-1β and TNF-α in the hippocampus of rats by PCR or western blot after the administration of one or seven doses. Next, the effects of the anti-seizure drugs were investigated on the rise in cytokine expression induced by lipopolysaccharides (LPS) inoculation in vivo. To validate our methods, the changes induced by the pro-convulsive agents 4-aminopyridine, pentylenetetrazole and pilocarpine were also tested. Finally, the effect of the anti-seizure drugs on seizures and on the concomitant rise in pro-inflammatory cytokine expression induced by 4-aminopyridine was explored. Results show that vinpocetine and carbamazepine reduced the expression of IL-1β and TNF-α from basal conditions, and the increase in both pro-inflammatory cytokines induced by LPS. In contrast, valproic acid failed to reduce both the expression of the cytokines from basal conditions and the rise in IL-1β and TNF-α expression induced by LPS. Tonic-clonic seizures induced either by 4-aminopyridine, pentylenetetrazole or pilocarpine increased the expression of IL-1β and TNF-α markedly. 4-aminopyridine-induced changes were reduced by all the tested anti-seizure drugs, although valproic acid was less effective. We conclude that the anti-seizure drugs, vinpocetine and carbamazepine, whose mechanisms of action involve a decrease in ion channels permeability, also reduce cerebral inflammation. The mechanism of action of anti-seizure drugs like vinpocetine and carbamazepine involves a decrease in Na(+) channels permeability. We here propose that this mechanism of action also involves a decrease in cerebral inflammation.

Keywords: 4-aminopyridine; Anti-epileptic drugs; brain inflammation; epilepsy; lipopolysaccharides; sodium channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Aminopyridine / antagonists & inhibitors
  • 4-Aminopyridine / pharmacology
  • Animals
  • Anticonvulsants / pharmacology*
  • Behavior, Animal / drug effects
  • Blotting, Western
  • Carbamazepine / pharmacology*
  • Convulsants / pharmacology
  • DNA, Complementary / biosynthesis
  • DNA, Complementary / genetics
  • Epilepsy, Tonic-Clonic / chemically induced
  • Epilepsy, Tonic-Clonic / physiopathology
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Interleukin-1beta / antagonists & inhibitors
  • Interleukin-1beta / biosynthesis*
  • Lipopolysaccharides / pharmacology
  • Male
  • Polymerase Chain Reaction
  • Rats
  • Rats, Wistar
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / biosynthesis*
  • Valproic Acid / pharmacology*
  • Vinca Alkaloids / pharmacology*

Substances

  • Anticonvulsants
  • Convulsants
  • DNA, Complementary
  • Interleukin-1beta
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Vinca Alkaloids
  • Carbamazepine
  • vinpocetine
  • Valproic Acid
  • 4-Aminopyridine